Immunotherapy in head and neck squamous cell carcinoma: An updated review
Parmar, K., Mohamed, A., Vaish, E., Thawani, R., Cetnar, J., Thein, K.Z.
Published in Cancer treatment and research communications (2022)
Published in Cancer treatment and research communications (2022)
Get full text
Journal Article
Risk of secondary hematological malignancies and hematological toxicities in recurrent ovarian cancer patients treated with poly adenosine diphosphate ribose polymerase (PARP) inhibitors maintenance
Thein, K.Z., Sultan, A., Zaw, M.H., Han, M.M., Yendala, R., Zin, M.M., Awasthi, S., D'Cunha, N., Hardwicke, F., Jones, C.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
A systematic review and meta- analysis of randomized controlled trials to evaluate the risk of gastrointestinal and hepatic toxicities in patients with recurrent ovarian cancer treated with poly adenosine diphosphate ribose polymerase inhibitors maintenance
Thein, K.Z., Sultan, A., Zaw, M.H., Han, M.M., Hein, A.M., Aung, H.H., Awasthi, S., Jones, C., Hardwicke, F., D'Cunha, N.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Updated meta-analysis of randomized controlled trials (RCTs) to determine the CDK 4/6 inhibitors associated venous thromboembolism (VTE) risk in hormone receptor-positive breast cancer (BC) patients
Thein, K.Z., Ball, S., Zaw, M.H., Tun, A.M., Quirch, M., Hardwicke, F., D'Cunha, N., Tijani, L., Jones, C., Oo, T.H.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Incidence of cardiac toxicities in patients with advanced non-small cell lung cancer treated with osimertinib: A combined analysis of two phase III randomized controlled trials
Thein, K.Z., Swarup, S., Ball, S., Quirch, M., Vorakunthada, Y., Htwe, K.K., D'Cunha, N., Hardwicke, F., Awasthi, S., Tijani, L.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Risk of health-related quality of life events and pulmonary toxicities in recurrent ovarian cancer patients treated with poly adenosine diphosphate ribose polymerase (PARP) inhibitors maintenance
Thein, K.Z., Sultan, A., Zaw, M.H., Han, M.M., Yu, N.H., Igid, H.P., Jones, C., D'Cunha, N., Awasthi, S., Hardwicke, F.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
P3.CR-03 Pulmonary Spindle Cell Neoplasm - Neoadjuvant Treatment and Response
Ismail, A., Sultan, A., Thein, K., Swarup, S., Nugent, K., Graham, S., Tijani, L., Hardwicke, F.
Published in Journal of thoracic oncology (01.10.2018)
Published in Journal of thoracic oncology (01.10.2018)
Get full text
Journal Article
P3.01-100 Risk of Gastrointestinal and Hepatic Toxicities in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Osimertinib
Thein, K., Swarup, S., Ball, S., Quirch, M., Vorakunthada, Y., Khan, S., Hardwicke, F., Awasthi, S., Tijani, L.
Published in Journal of thoracic oncology (01.10.2018)
Published in Journal of thoracic oncology (01.10.2018)
Get full text
Journal Article
P3.01-93 Osimertinib-Related Hematological and Pulmonary Toxicities in Advanced NSCLC Patients: Combined Analysis of Phase III Trials
Swarup, S., Thein, K., Ball, S., Quirch, M., Vorakunthada, Y., Sultan, A., Hardwicke, F., Tijani, L., Awasthi, S.
Published in Journal of thoracic oncology (01.10.2018)
Published in Journal of thoracic oncology (01.10.2018)
Get full text
Journal Article
1761PRisk of health-related quality of life events and pulmonary toxicities in recurrent ovarian cancer patients treated with poly adenosine diphosphate ribose polymerase (PARP) inhibitors maintenance
Thein, K Z, Sultan, A, Zaw, M H, Han, M M, Yu, N H, Igid, H P, Jones, C, D'Cunha, N, Awasthi, S, Hardwicke, F
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
1388PIncidence of cardiac toxicities in patients with advanced non-small cell lung cancer treated with osimertinib: A combined analysis of two phase III randomized controlled trials
Thein, K Z, Swarup, S, Ball, S, Quirch, M, Vorakunthada, Y, Htwe, K K, D'Cunha, N, Hardwicke, F, Awasthi, S, Tijani, L
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
1691PUpdated meta-analysis of randomized controlled trials (RCTs) to determine the CDK 4/6 inhibitors associated venous thromboembolism (VTE) risk in hormone receptor-positive breast cancer (BC) patients
Thein, K Z, Ball, S, Zaw, M H, Tun, A M, Quirch, M, Hardwicke, F, D'Cunha, N, Tijani, L, Jones, C, Oo, T H
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
969PA systematic review and meta- analysis of randomized controlled trials to evaluate the risk of gastrointestinal and hepatic toxicities in patients with recurrent ovarian cancer treated with poly adenosine diphosphate ribose polymerase inhibitors maintenance
Thein, K Z, Sultan, A, Zaw, M H, Han, M M, Hein, A M, Aung, H H, Awasthi, S, Jones, C, Hardwicke, F, D'Cunha, N
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
961PRisk of secondary hematological malignancies and hematological toxicities in recurrent ovarian cancer patients treated with poly adenosine diphosphate ribose polymerase (PARP) inhibitors maintenance
Thein, K Z, Sultan, A, Zaw, M H, Han, M M, Yendala, R, Zin, M M, Awasthi, S, D'Cunha, N, Hardwicke, F, Jones, C
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
P2.04-46 Tolerability and Treatment-Related Adverse Events of Upfront Pembrolizumab Combination Regimens in Advanced NSCLC Patients
Jahan, N., Thein, K., Sultan, A., Swarup, S., Mogollon-Duffo, F., Adhikari, N., Arevalo, M., Htut, T., Naing, T., D’Cunha, N., Rehman, S., Hardwicke, F., Tijani, L.
Published in Journal of thoracic oncology (01.10.2019)
Published in Journal of thoracic oncology (01.10.2019)
Get full text
Journal Article